Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.90

-1.7%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hippieslayer who wrote (21519)	5/28/1998 8:38:00 PM
From: Henry Niman	Read Replies (1) of 32384

Here's what Dow Jones said about yesterday's press release: Dow Jones Newswires -- May 27, 1998 Ligand Files NDA For Panretin Gel In Kaposi's Sarcoma SAN DIEGO (Dow Jones)--Ligand Pharmaceuticals Inc. (LGND) submitted a new drug application to the Food and Drug Administration for Panretin gel, its AIDS-related Kaposi's sarcoma topical treatment. As reported March 26, the pharmaceutical company said final analysis of its Phase III pivotal trial data indicated 37.1% of patients treated with Panretin gel experienced complete or partial response compared with 6.9% of patients using a placebo.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next